GBGB1411253.6A
GB201411253D0
(en)
|
2014-06-25 |
2014-06-25 |
Prodrug
|
KR1020167033376A
KR102421929B1
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
SG11201608808TA
SG11201608808TA
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
MYPI2016002193A
MY183198A
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
MX2016015629A
MX2016015629A
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug.
|
PCT/GB2015/051857
WO2015198058A1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
ES15733498.8T
ES2655820T3
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine prodrug
|
NZ765508A
NZ765508A
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
TW108132019A
TWI765176B
(en)
|
2014-06-25 |
2015-06-25 |
Formulations of phosphate derivatives
|
PT157334988T
PT3119794T
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
HUE15733498A
HUE036011T2
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
SG11201608809RA
SG11201608809RA
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
AU2015278900A
AU2015278900B2
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
HUE15733497A
HUE053240T2
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
MX2020004054A
MX2020004054A
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug.
|
TW109115415A
TWI758728B
(en)
|
2014-06-25 |
2015-06-25 |
Prodrug
|
RS20180003A
RS56752B1
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
TW104120671A
TWI695718B
(en)
|
2014-06-25 |
2015-06-25 |
Prodrug
|
DK15733497.0T
DK3160978T3
(en)
|
2014-06-25 |
2015-06-25 |
GEMCITABIN PRODUCTS
|
HRP20230584TT
HRP20230584T1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
ES20187951T
ES2948660T3
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
DK15733498.8T
DK3119794T3
(en)
|
2014-06-25 |
2015-06-25 |
FORMULA CONTAINING A GEMCITABIN PRODRUG
|
SI201531314T
SI3160978T1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
CA2944966A
CA2944966C
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
NZ725205A
NZ725205A
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
MYPI2016002149A
MY186584A
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
US15/308,491
US10662213B2
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
EP15733498.8A
EP3119794B1
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
JP2016574458A
JP6855248B2
(en)
|
2014-06-25 |
2015-06-25 |
Formulation containing gemcitabine-prodrug
|
KR1020227019095A
KR102563040B1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
PL15733498T
PL3119794T3
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
JP2016573536A
JP6982957B2
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrug
|
HUE20187951A
HUE062474T2
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
KR1020227023672A
KR20220104270A
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
EP20187951.7A
EP3757112B1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
RS20200953A
RS60968B1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
MX2016015628A
MX2016015628A
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs.
|
EP15733497.0A
EP3160978B1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
MX2021001140A
MX2021001140A
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs.
|
LTEP15733497.0T
LT3160978T
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
AU2015278899A
AU2015278899B2
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
EA201692312A
EA034890B1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
EP17189351.4A
EP3269391A1
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
NZ725009A
NZ725009B2
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
PCT/GB2015/051858
WO2015198059A1
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
US15/308,475
US10117888B2
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
CN201911065790.0A
CN110882268A
(en)
|
2014-06-25 |
2015-06-25 |
Formulations comprising gemcitabine prodrugs
|
BR112016025787-1A
BR112016025787B1
(en)
|
2014-06-25 |
2015-06-25 |
PHARMACEUTICAL FORMULATION COMPRISING GENCITABIN-[PHENYL-(BENZOXY-L-ALANINYL)]-PHOSPHATE, ITS USE IN THE TREATMENT OF CANCER, METHOD OF PREPARATION AND KIT COMPRISING THE SAME
|
CN201580034740.XA
CN106459129B
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
EA201692422A
EA033046B1
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
PT157334970T
PT3160978T
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
ES15733497T
ES2811268T3
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
CA2945938A
CA2945938C
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
NO15733498A
NO3119794T3
(en)
|
2014-06-25 |
2015-06-25 |
|
SG10201907898SA
SG10201907898SA
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
CN201580034742.9A
CN106470672B
(en)
|
2014-06-25 |
2015-06-25 |
Preparation including gemcitabine prodrug
|
SI201530157T
SI3119794T1
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
TW104120487A
TWI674097B
(en)
|
2014-06-25 |
2015-06-25 |
Formulations of phosphate derivatives
|
MEP-2020-171A
ME03817B
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
KR1020167033632A
KR102407935B1
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
PL15733497T
PL3160978T3
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
CN202010140546.2A
CN111214480A
(en)
|
2014-06-25 |
2015-06-25 |
Gemcitabine prodrugs
|
LTEP15733498.8T
LT3119794T
(en)
|
2014-06-25 |
2015-06-25 |
Formulation comprising a gemcitabine-prodrug
|
IL248345A
IL248345B
(en)
|
2014-06-25 |
2016-10-13 |
Formulation comprising a gemcitabine-prodrug
|
IL248642A
IL248642B
(en)
|
2014-06-25 |
2016-10-31 |
Gemcitabine prodrugs
|
PH12016502552A
PH12016502552A1
(en)
|
2014-06-25 |
2016-12-20 |
Formulation comprising a gemcitabine-prodrug
|
CL2016003260A
CL2016003260A1
(en)
|
2014-06-25 |
2016-12-20 |
Gemcitabine prodrugs
|
PH12016502553A
PH12016502553B1
(en)
|
2014-06-25 |
2016-12-20 |
Gemcitabine prodrugs
|
CL2016003261A
CL2016003261A1
(en)
|
2014-06-25 |
2016-12-20 |
Formulation comprising a gemcitabine prodrug
|
HK18103928.1A
HK1244437A1
(en)
|
2014-06-25 |
2017-02-04 |
Formulation comprising a gemcitabine-prodrug
|
HRP20180007TT
HRP20180007T1
(en)
|
2014-06-25 |
2018-01-03 |
Formulation comprising a gemcitabine-prodrug
|
CY20181100037T
CY1119772T1
(en)
|
2014-06-25 |
2018-01-11 |
CONSTRUCTION CONTAINED BY GEMSITABIN PRODUCT
|
US16/142,948
US10786523B2
(en)
|
2014-06-25 |
2018-09-26 |
Formulation comprising a gemcitabine-prodrug
|
AU2019204557A
AU2019204557B2
(en)
|
2014-06-25 |
2019-06-27 |
Formulation comprising a gemcitabine-prodrug
|
AU2019216626A
AU2019216626B2
(en)
|
2014-06-25 |
2019-08-13 |
Gemcitabine prodrugs
|
JP2020012388A
JP6970221B2
(en)
|
2014-06-25 |
2020-01-29 |
Gemcitabine-formation containing prodrug
|
IL272724A
IL272724B
(en)
|
2014-06-25 |
2020-02-17 |
Gemcitabine prodrug for use in treating cancer
|
JP2020076384A
JP6970236B2
(en)
|
2014-06-25 |
2020-04-22 |
Gemcitabine prodrug
|
US16/865,527
US11629164B2
(en)
|
2014-06-25 |
2020-05-04 |
Gemcitabine prodrugs
|
IL276199A
IL276199B
(en)
|
2014-06-25 |
2020-07-21 |
Formulation comprising a gemcitabine-prodrug
|
CY20201100745T
CY1123389T1
(en)
|
2014-06-25 |
2020-08-10 |
GEMCITABINE PRODUCTS
|
HRP20201264TT
HRP20201264T1
(en)
|
2014-06-25 |
2020-08-11 |
Gemcitabine prodrugs
|
US17/010,338
US11040051B2
(en)
|
2014-06-25 |
2020-09-02 |
Formulation comprising a gemcitabine-prodrug
|
US17/324,835
US11707477B2
(en)
|
2014-06-25 |
2021-05-19 |
Formulation comprising a gemcitabine-prodrug
|
JP2021176770A
JP7329025B2
(en)
|
2014-06-25 |
2021-10-28 |
Formulations containing gemcitabine-prodrugs
|